Sugi K, Saitoh O, Matsuse R, Tabata K, Uchida K, Kojima K, Nakagawa K, Tanaka S, Teranishi T, Hirata I, Katsu K
Second Department of Internal Medicine, Osaka Medical College, Takatsuki, Japan.
Am J Gastroenterol. 1999 May;94(5):1304-12. doi: 10.1111/j.1572-0241.1999.01081.x.
Our aim was to investigate the prevalence of antineutrophil cytoplasmic antibodies (ANCA) in Japanese patients with ulcerative colitis (UC) and Crohn's disease (CD), and the putative antigens recognized by perinuclear staining pattern ANCA (p-ANCA)-positive sera.
Sera from UC (n = 52) and CD (n = 43) patients, and from healthy controls (n = 74) were studied. The indirect immunofluorescence (IIF) method was used for the detection of ANCA and its binding pattern. p-ANCA-positive sera were studied further for putative antigens. ELISAs using lactoferrin (Lf), myeloperoxidase (MPO), and cathepsin G (Cat G) as antigens were performed.
ANCA was positive in 40 of the 52 (76.9%) UC (p-ANCA in 33) and in 32 of the 43 (74.4%) CD (p-ANCA in 31) patients. UC and CD patients showed significantly higher titers of p-ANCA than controls; however, no significant difference was observed between UC and CD. In UC, 23, 17, and nine of the 33 patients with p-ANCA-positive sera showed reactivity with Lf, MPO, and Cat-G, respectively. In CD, 21, 20, and 11 of the 31 patients with p-ANCA-positive sera showed reactivity with Lf, MPO, and Cat-G, respectively. Fourteen of the UC and six of the CD patients showed reactivity with two different antigens, and seven of the UC and 11 of the CD patients showed reactivity with all three antigens. The presence of anti-Lf and anti-MPO antibodies was further confirmed by Western blotting.
ANCA is useful in distinguishing patients with IBD from normal subjects but is not sufficient for the differential diagnosis of CD and UC. p-ANCA reactivity might be derived from the recognition of heterogeneous neutrophil-associated antigens.
我们的目的是调查日本溃疡性结肠炎(UC)和克罗恩病(CD)患者中抗中性粒细胞胞浆抗体(ANCA)的患病率,以及核周型ANCA(p-ANCA)阳性血清所识别的假定抗原。
研究了UC患者(n = 52)、CD患者(n = 43)以及健康对照者(n = 74)的血清。采用间接免疫荧光(IIF)法检测ANCA及其结合模式。对p-ANCA阳性血清进一步研究其假定抗原。进行了以乳铁蛋白(Lf)、髓过氧化物酶(MPO)和组织蛋白酶G(Cat G)为抗原的酶联免疫吸附测定(ELISA)。
52例UC患者中有40例(76.9%)ANCA阳性(33例为p-ANCA阳性),43例CD患者中有32例(74.4%)ANCA阳性(31例为p-ANCA阳性)。UC和CD患者的p-ANCA滴度显著高于对照组;然而,UC和CD之间未观察到显著差异。在UC中,33例p-ANCA阳性血清患者中分别有23例、17例和9例与Lf、MPO和Cat-G发生反应。在CD中,31例p-ANCA阳性血清患者中分别有21例、20例和11例与Lf、MPO和Cat-G发生反应。14例UC患者和6例CD患者与两种不同抗原发生反应,7例UC患者和11例CD患者与所有三种抗原发生反应。通过蛋白质印迹法进一步证实了抗Lf和抗MPO抗体的存在。
ANCA有助于将炎症性肠病患者与正常受试者区分开来,但不足以用于CD和UC的鉴别诊断。p-ANCA反应性可能源于对异质性中性粒细胞相关抗原的识别。